Recently, we have shown that the immune infiltration features in a primary tumor resection studied with multiplexed IF (PD-L1, PD-1, CD8, CD68, FOXP3, and CK) could reliably predict recurrence in patients with low-grade, early-stage endometrial cancer, outperforming the molecular subtypes22. The gene discussed is CD68; the disease is endometrial cancer.